Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Jun. 30, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 144,575	$ 18,300
Accounts receivable	126,688
Total current assets	271,263	18,300
Property and equipment, less accumulated depreciation of $30,480 and $18,611	130,883	17,752
Warehouse building		15,000
Goodwill	7,685,636
Intangible properties	25,000
Total other assets	7,841,519	32,752
TOTAL ASSETS	8,112,782	51,052
CURRENT LIABILITIES
Accounts payable	85,939	31,657
Accrued interest	169,145	74,984
Accrued executive compensation	58,333
Notes payable-third parties	435,000	390,000
Loans payable, related party	78,069	2,250
Contingent consideration	5,764,227
Derivative liability	327,947	1,180,680
Total current liabilities	6,918,660	1,679,571
TOTAL LIABILITIES	6,918,660	1,679,571
Commitments and contingencies
Mezzanine Equity:
Common stock to be issued upon conversion of Series L Preferred Stock	1,825,000	2,899,488
Total mezzanine equity	1,825,000	2,899,488
STOCKHOLDERS’ DEFICIENCY
Additional paid- in capital Class A common stock	161,073,727	159,999,238
Additional paid- in capital preferred stock	1,827,285	1,472,285
Exchange shares to be issued	1,921,409
Common stock to be issued	30,000	30,000
Accumulated deficit	(166,952,147)	(167,478,377)
Total stockholders’ deficiency	(630,878)	(4,528,007)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY	8,112,782	51,052
Series K Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock value
Series L Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock value	4	3
Common Class A [Member]
STOCKHOLDERS’ DEFICIENCY
Class A Common stock; 14,991,000,000 shares authorized, $.0001 par value, as of March 31, 2024 and June 30, 2023, there are 14,688,440,097 and 14,488,440,097 shares issued and outstanding, respectively	$ 1,468,844	$ 1,448,844